Business Wire6d
Boehringer Ingelheim India and EMRI Green Health Services a GVK Enterprise Sign MoU to Transform Pre-hospital Stroke Care in India
Boehringer Ingelheim is a biopharmaceutical company active in both human and animal health. As one of the industry’s top investors in Research and Development, the company focuses on developing ...
manilatimes8d
GREATER GOOD CHARITIES TEAMS UP WITH BOEHRINGER INGELHEIM FOR THE 10th ANNUAL SHELTER BOWL TO RAISE FUNDS FOR PETS IN NEED
Boehringer Ingelheim Animal Health is working on first-in-class innovation for the prediction, prevention, and treatment of diseases in animals. For veterinarians, pet owners, producers, and ...
Morningstar7d
GREATER GOOD CHARITIES TEAMS UP WITH BOEHRINGER INGELHEIM FOR THE 10th ANNUAL SHELTER BOWL TO RAISE FUNDS FOR PETS IN NEED
Boehringer Ingelheim Animal Health is working on first-in-class innovation for the prediction, prevention, and treatment of diseases in animals. For veterinarians, pet owners, producers ...
Boehringer’s nerandomilast meets primary endpoint in Phase III study FIBRONEER™-ILD, in progressive pulmonary fibrosis
Topline data from FIBRONEERâ„¢-ILD show that the investigational compound nerandomilast met its primary endpoint, which was the absolute change ...
pharmaphorum6d
Sanofi to be No.1 in consumer health via Boehringer multi-billion swap
Sanofi is to take on Boehringer Ingelheim's consumer health division in exchange for its animal health business Merial – the latest in a trend for multi-billion swaps in big pharma. The deal ...
Finanznachrichten27d
Boehringer Ingelheim Limited: Boehringer provides update on iclepertin Phase III program in schizophrenia
13 Boehringer Ingelheim is a biopharmaceutical company active in both human and animal health. As one of the industry's top investors in Research and Development, the company focuses on developing ...
The Week6d
Boehringer Ingelheim India and EMRI Green Health Services a GVK Enterprise Sign MoU to Transform Pre-hospital Stroke Care in India
About Boehringer Ingelheim Boehringer Ingelheim is a biopharmaceutical company active in both human and animal health. As one of the industry’s top investors in Research and Development, the company ...
nationthailand8d
Unite to cut carbon emissions with innovative waste management
Charoen Pokphand Foods PCL (CPF), a leading integrated agro-industrial and food business, has signed a Memorandum of Understanding (MOU) with Boehringer Ingelheim Animal Health (Thailand) Co., Ltd., a ...
Poultry Medicine/Pharmaceuticals Market to Hit USD 6.68 Billion by 2029 with 5.9% CAGR | MarketsandMarkets
The poultry medicine/pharmaceuticals market valued at US$ 4.73 billion in 2023, is forecasted to grow at a robust CAGR of 5.9%, reaching US$ ...
Pharmaceutical Technology24d
BI-765845 by Boehringer Ingelheim International for Myocardial Infarction: Likelihood of Approval
BI-765845 is under clinical development by Boehringer Ingelheim International and currently in Phase ... It offers an array of products including human diseases, animal health care products, and ...
Wall Street Journal2d
Elanco Animal Health Inc.
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...